Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EVOK NYSE:PBH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVOKEvoke Pharma$4.61-5.5%$3.39$1.94▼$12.32$6.87M-0.04699,668 shs104,667 shsPBHPrestige Consumer Healthcare$75.20+0.0%$83.39$64.94▼$90.04$3.72B0.43315,138 shs565,155 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVOKEvoke Pharma-4.87%-30.19%+68.86%+126.98%-28.78%PBHPrestige Consumer Healthcare-0.02%-4.75%-10.26%-6.26%+4.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVOKEvoke Pharma0.8265 of 5 stars0.05.00.00.03.10.00.0PBHPrestige Consumer Healthcare3.8992 of 5 stars2.32.00.03.53.41.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVOKEvoke Pharma 0.00N/AN/AN/APBHPrestige Consumer Healthcare 2.50Moderate Buy$93.3324.12% UpsideCurrent Analyst Ratings BreakdownLatest BET, 888, EVOK, and PBH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025PBHPrestige Consumer HealthcareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVOKEvoke Pharma$10.25M0.67N/AN/A$4.74 per share0.97PBHPrestige Consumer Healthcare$1.14B3.27$5.22 per share14.41$37.04 per share2.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVOKEvoke Pharma-$5.35M-$2.87N/A∞N/A-43.80%-101.91%-33.75%8/12/2025 (Estimated)PBHPrestige Consumer Healthcare$214.60M$4.2917.5315.802.2618.86%12.87%6.78%8/6/2025 (Estimated)Latest BET, 888, EVOK, and PBH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q1 2026PBHPrestige Consumer Healthcare$1.01N/AN/AN/A$260.71 millionN/A8/12/2025Q2 2025EVOKEvoke Pharma-$0.30N/AN/AN/A$3.80 millionN/A5/12/2025Q1 2025EVOKEvoke Pharma-$0.33-$0.51-$0.18-$0.51$3.32 million$3.08 million5/8/2025Q4 2025PBHPrestige Consumer Healthcare$1.30$1.32+$0.02$1.00$289.36 million$296.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVOKEvoke PharmaN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVOKEvoke PharmaN/A1.551.50PBHPrestige Consumer Healthcare0.554.202.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVOKEvoke PharmaN/APBHPrestige Consumer Healthcare99.95%Insider OwnershipCompanyInsider OwnershipEVOKEvoke Pharma2.29%PBHPrestige Consumer Healthcare1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVOKEvoke Pharma41.49 million1.46 millionNot OptionablePBHPrestige Consumer Healthcare54049.42 million48.72 millionOptionableBET, 888, EVOK, and PBH HeadlinesRecent News About These CompaniesWhat is Zacks Research's Forecast for PBH FY2026 Earnings?July 17 at 7:16 AM | marketbeat.comBank of New York Mellon Corp Sells 12,337 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 16 at 3:38 AM | marketbeat.comPrestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings ResultsJuly 15 at 12:39 AM | finance.yahoo.comPrestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings ResultsJuly 15 at 8:00 AM | globenewswire.comRice Hall James & Associates LLC Has $46.87 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 14 at 6:37 AM | marketbeat.comConcurrent Investment Advisors LLC Acquires Shares of 4,203 Prestige Consumer Healthcare Inc. (NYSE:PBH)July 12, 2025 | marketbeat.comPrincipal Financial Group Inc. Acquires 8,291 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)July 10, 2025 | marketbeat.comEULAV Asset Management Invests $1.67 Million in Prestige Consumer Healthcare Inc. (NYSE:PBH)July 7, 2025 | marketbeat.comPrestige Consumer Healthcare (NYSE:PBH) Raised to "Buy" at Wall Street ZenJuly 5, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Leeward Investments LLC MAJuly 4, 2025 | marketbeat.comInvestors in Prestige Consumer Healthcare (NYSE:PBH) have seen impressive returns of 121% over the past five yearsJuly 3, 2025 | finance.yahoo.comWhy Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term - NasdaqJuly 2, 2025 | nasdaq.comWhy Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-TermJune 30, 2025 | zacks.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Allspring Global Investments Holdings LLCJune 28, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of "Moderate Buy" from AnalystsJune 27, 2025 | marketbeat.comPrestige Consumer Healthcare Inc. (NYSE:PBH) Position Increased by Bessemer Group Inc.June 26, 2025 | marketbeat.comAvior Wealth Management LLC Grows Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)June 22, 2025 | marketbeat.comAdvisor Resource Council Buys Shares of 27,337 Prestige Consumer Healthcare Inc. (NYSE:PBH)June 21, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for PBH EarningsJune 19, 2025 | marketbeat.comBoston Trust Walden Corp Sells 12,345 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)June 19, 2025 | marketbeat.comAssenagon Asset Management S.A. Reduces Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)June 19, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesDon’t Miss These 2 Small Quantum Stocks Poised to PopBy Gabriel Osorio-Mazilli | June 24, 2025View Don’t Miss These 2 Small Quantum Stocks Poised to PopWhy Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback StocksJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?Pelosi Makes Big Bet on Broadcom—Here’s Why It MattersBy Gabriel Osorio-Mazilli | July 15, 2025View Pelosi Makes Big Bet on Broadcom—Here’s Why It MattersZscaler or CrowdStrike: Which Is the Better Buy in 2025?By Thomas Hughes | July 9, 2025View Zscaler or CrowdStrike: Which Is the Better Buy in 2025?BET, 888, EVOK, and PBH Company DescriptionsEvoke Pharma NASDAQ:EVOK$4.61 -0.27 (-5.53%) Closing price 04:00 PM EasternExtended Trading$4.50 -0.11 (-2.28%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.Prestige Consumer Healthcare NYSE:PBH$75.19 +0.03 (+0.03%) Closing price 03:59 PM EasternExtended Trading$75.11 -0.08 (-0.11%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
